#
Mektovi
  • Treatments
  • Melanoma
  • Metastatic

Mektovi

Generic name:binimetinibBIN-i-ME-ti-nib ]
Drug class:Multikinase inhibitors

Medically reviewed by Philip Thornton, DipPharm. Last updated on May 23, 2022.

What is Mektovi?

Mektovi is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Mektovi is a prescription medicine used in combination with another medicine called encorafenib (Braftovi) to treat melanoma (skin cancer) in people who have a "BRAF" gene mutation. These medicines are for use in treating melanoma that cannot be treated with surgery or has spread to other parts of the body.

Mektovi may also be used for purposes not listed in this medication guide.

Warnings

Mektovi can cause birth defects. Do not use if you are pregnant. Avoid getting pregnant while using Mektovi and for at least 30 days after your last dose.

Before taking this medicine

You should not use Mektovi if you are allergic to binimetinib.

Tell your doctor if you have ever had:

  • heart disease, high blood pressure;

  • lung disease;

  • a muscle disorder;

  • liver or kidney disease;

  • eye problems (especially a problem with your retina); or

  • bleeding problems, or a blood clot.

Do not use Mektovi if you are pregnant. It could harm the unborn baby or cause birth defects. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 30 days after your last dose.

Tell your doctor if you think you may be pregnant. You may need to have a negative pregnancy test before starting this treatment.

You should not breastfeed while using this medicine, and for at least 3 days after your last dose....